Skip to content

GeneDx Holdings WGS Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$77.81M-$21.02M
$26.36M+17.7%$25.22M+14.9%$23.9M+6.3%$23.36M-7.4%$22.38M-26.2%
$37.18M+174%$32.16M+252%$25.23M+369%$18.28M+740%$13.57M+1,745%
-$6.22M-227%$36.37M+228%$33.19M+160%$13.02M+114%-$1.9M+98.7%
$19.34M+73.0%$19.02M+246%$17.72M+268%$12.19M+185%$11.18M+96.3%
-$69.36M-71.8%-$61.52M-104%-$50.96M-47.8%-$54.03M-0.3%-$40.38M+4.8%
$72.9M+25.0%$48.03M+8.7%$55.86M-7.3%$59.06M+27.6%$58.32M+7.9%
-$5.78M$19.79M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does GeneDx Holdings's cash flow data come from?
Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.